281
Views
22
CrossRef citations to date
0
Altmetric
Review

Sensitivity, specificity, positive and negative predictive values of identifying atrial fibrillation using administrative data: a systematic review and meta-analysis

, , , , &
Pages 753-767 | Published online: 23 Aug 2019

References

  • Andrade JG, Verma A, Mitchell LB, et al. 2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can J Cardiol. 2018;34:1371–1392. doi:10.1016/j.cjca.2018.08.02630404743
  • Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114:1453–1468. doi:10.1161/CIRCRESAHA.114.30321124763464
  • Chubak J, Pocobelli G, Weiss NS. Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol. 2012;65:343–349 e342. doi:10.1016/j.jclinepi.2011.09.00222197520
  • Navar-Boggan AM, Rymer JA, Piccini JP, et al. Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke. Am Heart J. 2015;169:39–44 e32. doi:10.1016/j.ahj.2014.09.01425497246
  • Jensen PN, Johnson K, Floyd J, et al. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1:141–147. doi:10.1002/pds.231722262600
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.3802833
  • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634. doi:10.1136/bmj.315.7109.6299310563
  • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101.7786990
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi:10.1136/bmj.327.7414.55712958120
  • Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1–48. doi:10.18637/jss.v036.i03
  • Tu K, Nieuwlaat R, Cheng SY, et al. Identifying patients with atrial fibrillation in administrative data. Can J Cardiol. 2016;32:1561–1565. doi:10.1016/j.cjca.2016.06.00627742459
  • Sung SF, Hsieh CY, Lin HJ, et al. Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database. Int J Cardiol. 2016;215:277–282. doi:10.1016/j.ijcard.2016.04.06927128546
  • Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Identifying hypertension-related comorbidities from administrative data: what’s the optimal approach? Am J Med Qual. 2004;19:201–206. doi:10.1177/10628606040190050415532912
  • Ruigomez A, Johansson S, Wallander MA, Rodriguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol. 2002;55:358–363.11927203
  • Baturova MA, Lindgren A, Carlson J, Shubik YV, Bertil Olsson S, Platonov PG. Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss? Europace. 2014;16:1714–1719. doi:10.1093/europace/euu16525013011
  • Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA. 2001;285:2370–2375. doi:10.1001/jama.285.18.237011343485
  • Alonso A, Agarwal SK, Soliman EZ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158:111–117. doi:10.1016/j.ahj.2009.05.01019540400
  • Go AS, Hylek EM, Phillips KA, et al. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation. 2000;102:11–13. doi:10.1161/01.cir.102.1.1110880408
  • Thigpen JL, Dillon C, Forster KB, et al. Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2015;8:8–14. doi:10.1161/CIRCOUTCOMES.113.00037125587093
  • Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke. 2005;36:1776–1781. doi:10.1161/01.STR.0000174293.17959.a116020772
  • White E. The effect of misclassification of disease status in follow-up studies: implications for selecting disease classification criteria. Am J Epidemiol. 1986;124:816–825. doi:10.1093/oxfordjournals.aje.a1144583532767
  • Chotchaisuwatana S, Jedsadayanmata A, Chaiyakunapruk N, Jampachaisri K. Validation of electronic medical database in patients with atrial fibrillation in community hospitals. J Med Assoc Thai. 2011;94:686–692.21696076
  • Glazer NL, Dublin S, Smith NL, et al. Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med. 2007;167:246–252. doi:10.1001/archinte.167.3.24617296879
  • Gilbert T, Neuburger J, Kraindler J, et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391:1775–1782. doi:10.1016/S0140-6736(18)30668-829706364
  • Macle L, Cairns J, Leblanc K, et al. 2016 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can J Cardiol. 2016;32:1170–1185. doi:10.1016/j.cjca.2016.07.59127609430
  • Kucharska-Newton AM, Heiss G, Ni H, et al. Identification of heart failure events in medicare claims: the Atherosclerosis Risk in Communities (ARIC) study. J Card Fail. 2016;22:48–55. doi:10.1016/j.cardfail.2015.07.01326211720
  • Shoaib A, Farag M, Nasir M, et al. Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. Eur J Heart Fail. 2016;18:556–563. doi:10.1002/ejhf.50526991150
  • Frost L, Andersen LV, Vestergaard P, Husted S, Mortensen LS. Trend in mortality after stroke with atrial fibrillation. Am J Med. 2007;120:47–53. doi:10.1016/j.amjmed.2005.12.02717208079
  • Norberg J, Backstrom S, Jansson JH, Johansson L. Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data. Clin Epidemiol. 2013;5:475–481. doi:10.2147/CLEP.S5342024353441
  • Sundboll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open. 2016;6:e012832. doi:10.1136/bmjopen-2016-012832
  • Rix TA, Riahi S, Overvad K, et al. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry. Scand Cardiovasc J. 2012;46:149–153. doi:10.3109/14017431.2012.67372822397620
  • Frost L, Vestergaard P. Caffeine and risk of atrial fibrillation or flutter: the Danish diet, cancer, and health study. Am J Clin Nutr. 2005;81:578–582. doi:10.1093/ajcn/81.3.57815755825
  • Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25:95–102. doi:10.1007/s10654-009-9404-119936945
  • Brophy MT, Snyder KE, Gaehde S, et al. Anticoagulant use for atrial fibrillation in the elderly. J Am Geriatr Soc. 2004;52:1151–1156. doi:10.1111/j.1532-5415.2004.52314.x15209654
  • Ruigomez A, Johansson S, Wallander MA, Garcia Rodriguez LA. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord. 2005;5:20. doi:10.1186/1471-2261-5-1716008832
  • Quan H, Parsons GA, Ghali WA. Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data. J Clin Epidemiol. 2004;57:366–372. doi:10.1016/j.jclinepi.2003.01.00215135837
  • Shen AY, Yao JF, Brar SS, Jorgensen MB, Wang X, Chen W. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation. Stroke. 2008;39:2736–2743. doi:10.1161/STROKEAHA.107.50858018635860
  • Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke. 2004;35:2362–2367. doi:10.1161/01.STR.0000141933.75462.c215331796
  • Munkholm SB, Jakobsen CJ, Mortensen PE, Lundbye-Christensen S, Andreasen JJ. Validation of post-operative atrial fibrillation in the Western Denmark Heart Registry. Dan Med J. 2015;62:A5162.26621393
  • Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011;306:2248–2254. doi:10.1001/jama.2011.161522081378
  • Hravnak M, Hoffman LA, Saul MI, et al. Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. Ann Thorac Surg. 2001;71:1491–1495. doi:10.1016/s0003-4975(01)02477-811383788